Codes / ICD10CM / C46.4

C46.4 Kaposi's sarcoma of gastrointestinal sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Kaposi's sarcoma of gastrointestinal sites
  • Medical Terms: Kaposi's sarcoma of gastrointestinal sites; C46.4

Summary

Kaposi's sarcoma of gastrointestinal sites is a type of cancer that forms in the lining of blood and lymph vessels within the gastrointestinal tract. It may present as tumors in areas such as the stomach, intestines, or other digestive organs, and can occur alongside or independently of skin or other organ involvement.

Causes

Kaposi's sarcoma of gastrointestinal sites is primarily caused by infection with the human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV). This virus alone does not typically cause the condition unless the immune system is compromised.

Risk Factors

  • Immune suppression (e.g., from HIV/AIDS or post-transplant immunosuppressive therapy).
  • Being male.
  • African or Mediterranean descent due to higher prevalence of HHV-8 infection.
  • Older age.

Symptoms

  • Gastrointestinal bleeding (e.g., blood in stool or vomit).
  • Abdominal pain or discomfort.
  • Nausea or vomiting.
  • Unexplained weight loss.
  • Obstruction of the digestive tract if tumors grow large enough.

Diagnosis

Diagnosis involves a physical examination and evaluation of symptoms, followed by a biopsy of affected gastrointestinal tissue. Imaging tests like endoscopy, CT scans, or MRIs may be used to assess the extent of involvement and identify lesions.

Treatment Options

Treatment depends on the extent of the disease and the patient's immune status. Options may include antiretroviral therapy (for HIV-related cases), chemotherapy, radiation therapy, or targeted treatments. Surgery may be considered for localized tumors or to relieve obstructions.

Prognosis and Follow-Up

Prognosis varies based on the patient's overall health, immune status, and the extent of gastrointestinal involvement. Regular follow-up with imaging and endoscopic evaluations is often recommended to monitor for recurrence or progression.

Complications

  • Severe gastrointestinal bleeding.
  • Digestive tract obstruction.
  • Perforation of the stomach or intestines.
  • Spread of the cancer to other organs.

Lifestyle & Prevention

  • Maintain a healthy immune system through proper medical care (e.g., HIV treatment if applicable).
  • Avoid known risk factors for HHV-8 infection, where possible.
  • Follow up with healthcare providers for regular screenings if at high risk.

When to Seek Professional Help

Seek immediate medical attention if you experience severe abdominal pain, uncontrolled bleeding, or signs of digestive tract obstruction (e.g., persistent vomiting, inability to pass stool).

Tips for Medical Coders

When coding for Kaposi's sarcoma of gastrointestinal sites (C46.4), ensure documentation specifies the gastrointestinal site(s) involved (e.g., stomach, intestines) and any associated symptoms or complications. Verify that the diagnosis aligns with clinical findings and that the code is not used for non-gastrointestinal Kaposi's sarcoma.

Book a walkthrough

C46.4 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.